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Abstract
Introduction: During the last 22 years we registered 1790 patients with incidentally found adrenal tumours (AI, adrenal incidentalomas).
In 351 of them, bilateral tumours were detected. The aim of our study was to analyze the character of bilateral tumours and summarize the
methods of their management.
Material and methods: In the whole group of 1790 patients, there were 1311 women and 479 men, aged 11-87 years. The group of patients
with bilateral adrenal tumours included 258 women and 93 men, 25-83 years old. Hormonal investigations and imaging examinations
were performed to search for subclinical adrenal hyperfunction and to define the malignant potential of the tumours.
Results: Sixty-nine patients were treated by surgery for oncological or endocrinological purposes (mainly pre-Cushing’s syndrome).
Histological findings included malignant tumours: metastases — 9, adrenal cancer — 7, and lymphomas — 5; and non-malignant tumo-
urs: adenomas — 24, nodular hyperplasia — 14, myelolipomas — 4, and pheochromocytomas — 4. Subclinical Cushing’s syndrome was
relatively more frequent in nodular hyperplasia (40%) than in adenomas (30%).
Conclusions: Indications for surgery were recommended in 20% of patients with bilateral AI, most frequently for adenomas, nodular
hyperplasia, and oncological pathologies, with a good prognosis in the non-malignant group.
(Pol J Endocrinol 2010; 61 (1): 69–73)
Key words: adrenal tumour, adrenal cancer, adrenal incidentaloma, subclinical Cushing’s syndrome, pheochromocytoma, cortisol, aldosterone,
metanephrines, androgens
Streszczenie
Wstęp: W okresie ostatnich 22 lat 1790 pacjentów z przypadkowo wykrytymi guzami nadnerczy (AI, adrenal incidentalomas) zostało zare-
jestrowanych w klinice. U 351 spośród nich rozpoznano obustronne guzy nadnerczy. Nasze badania miały na celu analizę charakteru
obustronnych guzów i podsumowanie metod postępowania w tych przypadkach.
Materiał i metody: W całej grupie 1790 pacjentów było 1311 kobiet i 479 mężczyzn, w wieku 11–87 lat. Grupa pacjentów z obustronnymi
guzami nadnerczy obejmowała 258 kobiet i 93 mężczyzn, w wieku 25–83 lat. Przeprowadzono badania hormonalne i obrazowe, w celu
poszukiwania podklinicznej nadczynności nadnerczy i określenia potencjału złośliwości guzów.
Wyniki: Chirurgicznie leczono 69 pacjentów, ze wskazań onkologicznych albo endokrynologicznych (głównie podkliniczny zespół Cu-
shinga). Wyniki badań histologicznych wykazały istnienie złośliwych zmian nowotworowych: przerzuty — 9, rak nadnercza — 7, chło-
niaki — 5 i niezłośliwych zmian: gruczolaki — 24, rozrost guzkowy — 14, myelolipoma — 4, pheochromocytoma — 4 przypadki. Podkli-
niczny zespół Cushinga występował względnie częściej w rozroście guzkowym (40%) niż w przypadkach gruczolaka (30%).
Wnioski: Wskazania do leczenia chirurgicznego ustalono u 20% pacjentów z obustronnymi guzami nadnerczy, najczęściej z powodu
gruczolaków, rozrostu guzkowego i złośliwych zmian nowotworowych; rokowanie było dobre w przypadkach nieonkologicznych.
(Endokrynol Pol 2010; 61 (1): 69–73)
Słowa kluczowe: guz nadnercza, rak nadnercza, incydentaloma nadnercza, podkliniczny zespół Cushinga, pheochromocytoma, kortyzol,
aldosteron, metanefryny, androgeny
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Introduction
During the last 22 years we observed 1790 patients with
incidentally found adrenal tumours, so-called adrenal
incidentalomas (AI). Our first publication on AI, in 1992,
was based on an analysis of 64 patients observed at our
department [1]. Since that time our group of patients
with AI has grown and is worthy of evaluation. The
number of the incidentally discovered adrenal tumo-
urs increased rapidly in the last 15–20 years. The gre-
atest cohort of patients with AI, in the literature, was
described by Mantero et al. [2], including 1096 patients
from 26 Italian endocrinological centres.
 Investigations made in patients with AI aim at eva-
luating criteria for surgery or for clinical observation.
The main indications for surgical treatment include
malignant tumours, both primary and metastatic. Sin-
ce some AI may secrete slightly increased amounts of
steroid hormones [3], a search for subclinical adrenal
hyperfunction is necessary to define the group also re-
commended for surgery. Similarly, investigation direc-
ted towards chromaffin tumour diagnosis is obligatory
in patients with suggestive imaging signs, because of
the well-known complications of these tumours. The
oncological and endocrinological indications for surge-
ry have been discussed in the literature [4–8]; however,
in bilateral adrenal tumours, additional difficulties may
arise in deciding which tumour should be removed. We
would like to present our opinion in this matter becau-
se we have observed a significant number of such pa-
tients with bilateral AI.
Material and methods
Material — 1790 patients with AI: 1311 women and
479 men (F/M ratio 2.7), aged 11–87 years. In this group,
there were 67 patients up to 30 years old (4%) and
644 patients over 60 years old (34%). The size of the tu-
mours ranged from 1.0 to 23.0 cm. In 836 patients the
tumour was right-sided (47%), in 603 — left-sided (33%),
and in 351 patients bilateral tumours were found (20%).
In the group with bilateral adrenal tumours, there
were 258 women and 93 men (F/M ratio 2.8), 25–83 years
old. The tumour diameters ranged from 1.0 to 13.0 cm.
In the majority of cases, the bilateral tumours were fo-
und at the time of first diagnosis, while in 15 patients
the second tumour appeared after an interval of 2 to
18 years (most frequently after 2 to 5 years).
The methods of investigation included 1) imaging
examinations: ultrasound scans (US), computed tomo-
graphy (CT) and magnetic resonance imaging (MRI),
2) hormonal studies, and 3) pathomorphological exa-
minations of the patients treated by surgery. US was
used as a screening method to search for anatomical
abnormalities and to control the tumour’s size in a long-
term observation of the patients not qualified for surgi-
cal treatment. Computed tomography was the main me-
thod of evaluation of the tumour’s size and for defi-
ning their imaging phenotype and malignant poten-
tial. The imaging phenotype was characterized by the
shape of the tumours, their margins, texture, attenu-
ation (density) on unenhanced CT, rapidity of washout
of contrast medium, presence of necrosis, haemorrha-
ge, pseudocysts or calcifications, and growth rate of the
tumour in a series of examinations. High density of the
tumour in the native phase of CT, with delayed washo-
ut of the contrast medium (< 50% after 10 min) and
size over 4.0 cm were considered important indications
for surgery. MRI was used mainly to differentiate ade-
nomas from non-adenomas, based on the presence or
lack of lipids in the tumours.
Hormonal studies included determination in the
serum of the blood of cortisol (circadian rhythm), de-
hydroepiandrostendione sulphate (DHEA-S), andro-
stendione and 17-OH progesterone concentration, pla-
sma ACTH levels and urinary diurnal excretion of free
cortisol or 17-hydroxycorticosteroids (17-OHCS),
17-ketosteroids (17-KS), aldosterone, and metanephri-
nes, if necessary. Serum cortisol was measured initially
by radioimmunoassay (RIA), and during last 10 years
by chemiluminescence assay (LIA) (Immulite 2000). Se-
rum DHEA-S, androstendione, 17-OH progesterone,
and aldosterone were measured by RIA. Plasma ACTH
was measured by an immunoradiometric method
(IRMA). Dynamic hormonal investigations included de-
xamethasone suppression test, 1 mg at 22:00 hours with
cortisol determination the next morning. The classic
Liddle’s test with use of 0.5 mg of dexamethasone eve-
ry six hours for two days (with free cortisol or 17-OHCS
and/or 17-KS determination on the second day) was also
carried out if necessary. In patients with possible dia-
gnosis of a chromaffin tumour, this test was definitely
contraindicated to avoid a pheochromocytoma crisis [9].
In patients with a probable diagnosis of non-classic
congenital adrenal hyperplasia, a 1–24ACTH test was per-
formed with cortisol and 17-OH progesterone measu-
rement at 0, 60, and 120 mintes of the test.
Pathomorphological studies of the removed tumo-
urs were also made, including histological and micro-
scopic evaluation as well as immunocytochemical exa-
minations.
Results
In the whole observed group, on the basis of the pre-
viously described methods, we diagnosed tumours that
were probably benign in 1590 patients. Malignancy was
diagnosed in 200 patients, and tumours of metastatic
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origin in 50 patients (2.8%).Primary malignant tumo-
urs were found in 150 patients (8.2%), with adrenal can-
cer in 134 cases (7.5% of the whole group).
Subclinical adrenal hyperfunction was detected in
140 patients (8%), most frequently pre-Cushing’s syn-
drome (6%), while subclinical hyperaldosteronism and
hyperandrogenism only in 1%. Chromaffin tumours
were found in 58 patients (3% of the whole group).
The results of our investigations allowed us to de-
termine indications for surgery, oncological or endo-
crinological, in 595 patients (33%). In the case of mali-
gnancy, a traditional open surgery was performed. In
patients with probable benign tumours less than 7.0 cm
in diameter, a laparoscopic method was used.
Among the group of 351 patients with bilateral tu-
mours, 69 patients were treated by surgery (20%), 27 of
them — bilaterally. Pathomorphological examinations
revealed adrenal carcinoma in 7 patients, metastatic
infiltration in 9, lymphoma in 4, adrenal adenoma in
24, adrenal hyperplasia in 15, myelolipoma in 4, and
pheochromocytoma in 4 patients. In the remaining
282 patients, benign adrenal tumours were suspected
without criteria for surgery. They were qualified for
long-term observation. Bilateral adrenal carcinoma was
found at the time of diagnosis in 5 patients, while in
2 patients an interval of 2 and 6 years was observed. Bila-
teral metastatic lesions were discovered at the same time,
as in cases of lymphoma. Bilateral pheochromocytomas
were found simultaneously in two patients, in one pa-
tient an interval of ten years was noticed. In one patient,
treated for pheochromocytoma, a contralateral tumour
appeared after 18 years, not identified histologically.
Additionally, in one patient, a right-sided pheochromo-
cytoma was associated with a left-sided adenoma.
Computed tomogaphy and MRI were our main so-
urces of knowledge on the size, imaging phenotype,
and malignant potential of the tumours in the patients
under study. Figure 1 presents a typical CT image of an
adrenal adenoma. In the patient presented in Figure 2,
as well as bilateral adrenal adenomas, an incidentally
found liposarcoma was identified by MRI. Figure 3
shows three pheochromocytomas in a male patient with
neurofibromatosis.
Rapid growth of adrenal tumours in a series of ima-
ging examinations was considered as an important in-
dication for surgery, suggesting an oncological origin
of such a clinical course. However, in a male patient in
whom on CT both tumours doubled their size within
three months (from 3.0 to 7.0 cm and from 2.0 to 4.5 cm,
respectively), microscopic examination revealed bilate-
ral nodular hyperplasia. Similarly, false information was
signalled by increased density of the tumour in two
cases: a neurofibroma and haemorrhagic necrosis in the
“suspected” tumours were diagnosed microscopically.
Hormonal investigations and clinical observation
revealed subclinical Cushing’s syndrome in 14 patients,
in two of them presenting only as secondary adrenal
insufficiency following removal of the tumour. In sum-
mary, pre-Cushing’s syndrome was diagnosed in 8 pa-
tients with adrenal adenoma (8/25 = 32%) and in 6 pa-
Figure 1. Bilateral adrenal adenomas on computed tomography
(CT). Low density in the ROIs (marked on the masses) is
characteristic for adenomas
Rycina 1. Obustronne gruczolaki nadnerczy w tomografii
komputerowej (CT). Mała gęstość w obszarach zainteresowania
(zaznaczone na masach) jest cechą charakterystyczną dla gruczolaków
Figure 2. Bilateral adrenal adenomas (arrows) in a patient with
incidentally found well differentiated retroperitoneal liposarcoma
on magnetic resonance imaging
Rycina 2. Obustronne gruczolaki nadnerczy (strzałki) u pacjenta
z przypadkowo wykrytym w rezonansie magnetycznym dobrze
zróżnicowanym zaotrzewnowym tłuszczakomięsakiem
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tients with nodular hyperplasia (6/15 = 40%). In these
patients, gradually reducing hydrocortisone dosing was
necessary postoperatively. Persistent pre-Cushing syn-
drome was observed in two patients following unilate-
ral adrenalectomy for nodular hyperplasia. Additional-
ly, in a male patient treated successfully for pre-Cu-
shing’s syndrome by unilateral adrenalectomy (micro-
scopically — nodular hyperplasia), subclinical adrenal
hyperfunction recurred three years later, presenting as
a painful myasthenia. A complete remission followed
the second adrenalectomy. In two patients with conge-
nital adrenal hyperplasia, hyperdense tumours were
observed in CT, with increased androgen values.
Two patients with recurrent contralateral adrenal
carcinoma, treated by surgery and Mitotane, are still
alive. In the group of 5 patients with simultaneously
diagnosed bilateral carcinoma, four patients died wi-
thin one to two years, despite surgery and chemothe-
rapy (Cisplatin, Etoposid, Doxorubicin). Only two pa-
tients with metastatic infiltrations are still alive, two and
four years after bilateral adrenalectomy. The patients
with bilateral lymphoma died within one to two years
following bilateral tumour removal. In the patients tre-
ated surgically for non-malignant tumours, the progno-
sis has been good. The remaining patients, not quali-
fied for surgery, have been carefully controlled by ima-
ging examinations and by cortisol and DHEA-S deter-
minations.
Discussion
The observation of a numerous group of patients with
adrenal incidentalomas, diagnosed and managed in the
same manner in a single clinical centre, has allowed
some useful conclusions to be reached in this matter. In
part, it was our experience from some previous publi-
cations [1, 4, 8, 10, 11]. In 2007 WF Young Jr presented
a report on 2005 patients collected from 13 studies fo-
und in the literature [7]. This article, therefore, could be
considered as a true encyclopaedia of adrenal inciden-
talomas; however, information on bilateral adrenal
masses and their management in this report appeared
to be very sparse.
The incidence of pre-Cushing’s syndrome and sub-
clinical hyperaldosteronism in our material did not dif-
fer significantly from the data presented by other en-
docrinological centres [7, 12]. An original our observa-
tion was the presence of a group of patients with subc-
linical androgens excess, not described in older [2, 6] or
in more recent publications [7, 12].
The main aim of imaging and hormonal studies in
adrenal incidentalomas is the selection of patients to be
treated by surgery. The oncological and endocrinologi-
cal criteria are well known and generally respected for
patients with unilateral adrenal tumours [4–8]. In bila-
teral tumours presenting subclinical adrenal hyperfunc-
tion, however, the decision could sometimes be pro-
blematic. In these patients, we decided to remove first
the tumour evidently greater in size, more rapidly gro-
wing, or presenting higher density in the first phase of
CT [8]. Such tactics appeared to be reasonable in the
majority of patients treated by surgery, in whom an
adenoma was diagnosed microscopically. In the case of
bilateral nodular hyperplasia, however, despite tran-
sient improvement following unilateral adrenalectomy,
in some cases pre-Cushing’s syndrome recurred within
one to three years. A rapid growth of the adrenal tumo-
urs, observed in CT, was also considered an important
oncological indication for surgery, with the dilemma of
whether it should be at once a bilateral adrenalectomy.
Previously described criteria for patients with subclini-
cal Cushing’s syndrome could also be useful in this gro-
up of patients.
In our study we present an exceptional group of
7 patients with bilateral adrenal carcinomas. Successful
treatment was achieved only in two patients, in whom
the malignant tumours did not appear simultaneously.
A bad prognosis has also been observed in the majority
of patients with bilateral metastatic infiltrations and lym-
phoma. A study on subclinical Addison’s disease was
possible in these cases. A careful postoperative obse-
rvation is necessary in all the patients; however, it must
be especially intensive in case of malignancy.
Figure 3. Multiple, bilateral adrenal pheochromocytomas
(3 tumors — arrows) on magnetic resonance imaging (MRI), in
patient with neurofibromatosis type 1. On axial T2-weighted
image, characteristic for pheochromocytoma, high signal is visible
Rycina 3. Liczne, obustronne guzy chromochłonne nadnerczy
(3 guzy — strzałki) w rezonansie magnetycznym (MRI) u pacjenta
z nerwiakowłókniakowatością typu 1. W osiowym obrazie
T2-zależnym widoczny jest sygnał o dużej intensywności chara-
kterystyczny dla guza chromochłonnego
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Conclusions
1. Criteria for surgery were established in 20% of pa-
tients with bilateral adrenal incidentalomas. Mali-
gnant tumours were diagnosed in 30% of the surgi-
cally treated patients.
2. Adrenal adenomas and nodular hyperplasia were
the most frequent benign bilateral tumours.
3. Persistent or recurrent subclinical Cushing’s syndro-
me was observed after unilateral adrenalectomy
only in some cases of nodular hyperplasia.
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